Being out of the stock market may seem safer right now, but it is far from a risk-free strategy.
Global Insight Services have recently published a report on Alzheimer’s Disease – Drug Pipeline Landscape, 2022. The pipeline landscape report provides
SVB Leerink decreased their price objective on AbbVie from $140.00 to $135.00 and set an “underperform” rating for the company in a research note on Friday.
Hormonal Contraceptive Market Share, Size, Trends, Industry Analysis Report, By Product; By Hormones (Combined Hormonal Contraceptive, Progestin-Only
Alector is a great speculative biotech play to look into. There are many other opportunities in the pipeline if none of the AD disease drug programs end up being successful. Read more.
CMI released the research report of Global HDAC Inhibitors Market Size, Share, Industry Trends, Demand Analysis Report by 2028, offers a detailed overview
The
Many of the dividend increases in September were modest. One exception was Accenture, which rewarded investors with a 15% boost.
The
All three of these stocks are attractively valued even though they’re beating the market this year.
The global medical aesthetics market is projected to reach USD 23 4 Billion by 2027 from USD 13 9 Billion in 2022 at a CAGR of 11 0 from 2022 to 2027 The demand for aesthetic treatments among men is ...
Are these defensive stocks the best stocks to buy during a recession?
The global Physician Dispensed Cosmeceuticals market is projected to showcase substantial growth in the upcoming years. This is largely attributable to
Neither company has any reason to worry about a recession either.
SVB Securities had to issue a clarification after releasing a false report concerning AbbVie’s (ABBV) guidance.
Shares of this drugmaker have far outpaced the S&P 500 index in 2022.
Shares of AbbVie Inc. slid 5.96% to $134.21 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...
The EMA is handing out a new recommendation surrounding J&J and AbbVie’s cancer drug Imbruvica and some medicines containing terlipressin. On Friday, the EMA’s safety committee (PRAC) stated that it has taken new measures to reduce the risk of respiratory failure and sepsis when medicines containing…
The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more…
With a price-to-earnings (or “P/E”) ratio of 20.1x AbbVie Inc. ( NYSE:ABBV ) may be sending bearish signals at the...